Spero Therapeutics Inc (SPRO)
1.175
-0.02
(-1.26%)
USD |
NASDAQ |
Nov 22, 15:58
Spero Therapeutics Market Cap: 64.06M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 64.88M |
| November 20, 2024 | 65.42M |
| November 19, 2024 | 63.24M |
| November 18, 2024 | 62.15M |
| November 15, 2024 | 64.33M |
| November 14, 2024 | 68.15M |
| November 13, 2024 | 71.42M |
| November 12, 2024 | 71.96M |
| November 11, 2024 | 72.51M |
| November 08, 2024 | 71.96M |
| November 07, 2024 | 71.42M |
| November 06, 2024 | 71.42M |
| November 05, 2024 | 71.15M |
| November 04, 2024 | 70.07M |
| November 01, 2024 | 64.09M |
| October 31, 2024 | 66.81M |
| October 30, 2024 | 70.07M |
| October 29, 2024 | 71.15M |
| October 28, 2024 | 70.07M |
| October 25, 2024 | 72.24M |
| October 24, 2024 | 68.44M |
| October 23, 2024 | 68.44M |
| October 22, 2024 | 68.98M |
| October 21, 2024 | 69.52M |
| October 18, 2024 | 69.52M |
| Date | Value |
|---|---|
| October 17, 2024 | 69.79M |
| October 16, 2024 | 67.35M |
| October 15, 2024 | 65.18M |
| October 14, 2024 | 66.81M |
| October 11, 2024 | 67.89M |
| October 10, 2024 | 67.35M |
| October 09, 2024 | 67.35M |
| October 08, 2024 | 67.35M |
| October 07, 2024 | 70.61M |
| October 04, 2024 | 70.61M |
| October 03, 2024 | 70.07M |
| October 02, 2024 | 71.15M |
| October 01, 2024 | 71.15M |
| September 30, 2024 | 72.78M |
| September 27, 2024 | 70.80M |
| September 26, 2024 | 69.18M |
| September 25, 2024 | 69.18M |
| September 24, 2024 | 69.18M |
| September 23, 2024 | 70.26M |
| September 20, 2024 | 71.89M |
| September 19, 2024 | 73.24M |
| September 18, 2024 | 72.43M |
| September 17, 2024 | 71.89M |
| September 16, 2024 | 74.05M |
| September 13, 2024 | 74.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
23.85M
Minimum
Aug 02 2022
628.51M
Maximum
Feb 08 2021
213.46M
Average
99.93M
Median
Nov 23 2022
Market Cap Benchmarks
| Arbutus Biopharma Corp | 664.17M |
| Equillium Inc | 25.89M |
| NovaBay Pharmaceuticals Inc | 3.349M |
| Palatin Technologies Inc | 18.74M |
| iBio Inc | 24.06M |
Market Cap Related Metrics
| PE Ratio | 14.69 |
| PS Ratio | 0.7053 |
| PEG Ratio | 0.0210 |
| Price to Book Value | 0.9779 |
| Price | 1.175 |
| Earnings Yield | 6.81% |
| PEGY Ratio | 0.0210 |
| Normalized PE Ratio | 14.69 |